Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134263426> ?p ?o ?g. }
- W3134263426 endingPage "1235" @default.
- W3134263426 startingPage "1235" @default.
- W3134263426 abstract "Multiple myeloma is a malignancy of terminally differentiated plasma cells, characterized by an extreme genetic heterogeneity that poses great challenges for its successful treatment. Due to antibody overproduction, MM cells depend on the precise regulation of the protein degradation systems. Despite the success of PIs in MM treatment, resistance and adverse toxic effects such as peripheral neuropathy and cardiotoxicity could arise. To this end, the use of rational combinatorial treatments might allow lowering the dose of inhibitors and therefore, minimize their side-effects. Even though the suppression of different cellular pathways in combination with proteasome inhibitors have shown remarkable anti-myeloma activities in preclinical models, many of these promising combinations often failed in clinical trials. Substantial progress has been made by the simultaneous targeting of proteasome and different aspects of MM-associated immune dysfunctions. Moreover, targeting deranged metabolic hubs could represent a new avenue to identify effective therapeutic combinations with PIs. Finally, epigenetic drugs targeting either DNA methylation, histone modifiers/readers, or chromatin remodelers are showing pleiotropic anti-myeloma effects alone and in combination with PIs. We envisage that the positive outcome of patients will probably depend on the availability of more effective drug combinations and treatment of early MM stages. Therefore, the identification of sensitive targets and aberrant signaling pathways is instrumental for the development of new personalized therapies for MM patients." @default.
- W3134263426 created "2021-03-15" @default.
- W3134263426 creator A5010654510 @default.
- W3134263426 creator A5014183602 @default.
- W3134263426 creator A5015689972 @default.
- W3134263426 creator A5035934730 @default.
- W3134263426 creator A5042629318 @default.
- W3134263426 creator A5070782187 @default.
- W3134263426 creator A5073258418 @default.
- W3134263426 creator A5077777265 @default.
- W3134263426 date "2021-03-11" @default.
- W3134263426 modified "2023-10-05" @default.
- W3134263426 title "The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma" @default.
- W3134263426 cites W1425194456 @default.
- W3134263426 cites W1500173675 @default.
- W3134263426 cites W1525705222 @default.
- W3134263426 cites W1544981048 @default.
- W3134263426 cites W1547555729 @default.
- W3134263426 cites W1696775091 @default.
- W3134263426 cites W1850271161 @default.
- W3134263426 cites W1894198394 @default.
- W3134263426 cites W1912976527 @default.
- W3134263426 cites W1970740484 @default.
- W3134263426 cites W1972903220 @default.
- W3134263426 cites W1973031804 @default.
- W3134263426 cites W1973562447 @default.
- W3134263426 cites W1973932751 @default.
- W3134263426 cites W1975305152 @default.
- W3134263426 cites W1982050984 @default.
- W3134263426 cites W1984863053 @default.
- W3134263426 cites W1986041760 @default.
- W3134263426 cites W1986560938 @default.
- W3134263426 cites W1987557775 @default.
- W3134263426 cites W1987974441 @default.
- W3134263426 cites W1990174038 @default.
- W3134263426 cites W1991899579 @default.
- W3134263426 cites W1992477322 @default.
- W3134263426 cites W1997952190 @default.
- W3134263426 cites W2004543856 @default.
- W3134263426 cites W2005833414 @default.
- W3134263426 cites W2010552629 @default.
- W3134263426 cites W2016274355 @default.
- W3134263426 cites W2018901115 @default.
- W3134263426 cites W2024968250 @default.
- W3134263426 cites W2025656486 @default.
- W3134263426 cites W2026642838 @default.
- W3134263426 cites W2029148944 @default.
- W3134263426 cites W2034266037 @default.
- W3134263426 cites W2040722278 @default.
- W3134263426 cites W2041535798 @default.
- W3134263426 cites W2042748226 @default.
- W3134263426 cites W2045522345 @default.
- W3134263426 cites W2050987476 @default.
- W3134263426 cites W2052169053 @default.
- W3134263426 cites W2056920544 @default.
- W3134263426 cites W2059495814 @default.
- W3134263426 cites W2060737851 @default.
- W3134263426 cites W2065327255 @default.
- W3134263426 cites W2065661645 @default.
- W3134263426 cites W2066379425 @default.
- W3134263426 cites W2066699439 @default.
- W3134263426 cites W2068412287 @default.
- W3134263426 cites W2070114538 @default.
- W3134263426 cites W2070814954 @default.
- W3134263426 cites W2072236227 @default.
- W3134263426 cites W2076194625 @default.
- W3134263426 cites W2076198902 @default.
- W3134263426 cites W2076680628 @default.
- W3134263426 cites W2078616374 @default.
- W3134263426 cites W2080264636 @default.
- W3134263426 cites W2082050061 @default.
- W3134263426 cites W2090156221 @default.
- W3134263426 cites W2095026025 @default.
- W3134263426 cites W2096735689 @default.
- W3134263426 cites W2098370110 @default.
- W3134263426 cites W2098991007 @default.
- W3134263426 cites W2104706142 @default.
- W3134263426 cites W2115205637 @default.
- W3134263426 cites W2120572492 @default.
- W3134263426 cites W2125678285 @default.
- W3134263426 cites W2127009065 @default.
- W3134263426 cites W2129890171 @default.
- W3134263426 cites W2130287531 @default.
- W3134263426 cites W2137205298 @default.
- W3134263426 cites W2137941402 @default.
- W3134263426 cites W2139161770 @default.
- W3134263426 cites W2140579395 @default.
- W3134263426 cites W2149402050 @default.
- W3134263426 cites W2153259757 @default.
- W3134263426 cites W2158287952 @default.
- W3134263426 cites W2158759120 @default.
- W3134263426 cites W2158900087 @default.
- W3134263426 cites W2161553904 @default.
- W3134263426 cites W2161574806 @default.
- W3134263426 cites W2162074485 @default.
- W3134263426 cites W2167412448 @default.
- W3134263426 cites W2171613528 @default.
- W3134263426 cites W2193545358 @default.